How much funding has Niowave, Inc. raised?

Niowave, Inc. has raised $19.9M in total funding, most recently a Grant round.

When was Niowave, Inc. founded?

Niowave, Inc. was founded in 2015.

Where is Niowave, Inc. headquartered?

Niowave, Inc. is headquartered in Lansing, Michigan, United States.

What industry is Niowave, Inc. in?

Niowave, Inc. operates in Biotech, Defense Tech, Healthcare.

How many employees does Niowave, Inc. have?

Niowave, Inc. has 51-200 employees.

Niowave, Inc.

Q: Who are Niowave, Inc.'s investors?

Niowave, Inc.'s investors include U.S. Department of Energy Loan Programs Office, Red Cedar Ventures.

Accelerating the Fight Against Cancer

Lansing, United States · Founded 2015 · $19.9M raised

Biotech

Defense Tech

Healthcare

Headquarters: Lansing, Michigan
Employees: 51–200
Founded: 2015
Business Model: B2B

Website: niowaveinc.com
Total Funding: $19.9M
Last Round: $1.7M GrantMar 2021
Rounds: 6

About

Niowave is an industry-leading supplier of medical radioisotopes, specializing in Actinium-225 (Ac-225) and other isotopes used in targeted cancer therapies. Founded in 2005 as a spinoff from the National Superconducting Cyclotron Lab, the company produces radioisotopes through proprietary superconducting electron linear accelerator technology. Niowave ships cancer treatments from its Lansing, Michigan facilities and addresses supply chain bottlenecks for clinical development and commercialization.

Summary

Niowave, Inc. is a Biotech company based in Lansing, United States, founded in 2015. It has raised $19.9M in total across 6 rounds, most recently a $1.7M Grant round in Mar 2021. Investors include U.S. Department of Energy Loan Programs Office and Red Cedar Ventures.